_version_ 1783459436913754112
author Walle, Lieselotte Vande
Stowe, Irma B.
Šácha, Pavel
Lee, Bettina L.
Demon, Dieter
Fossoul, Amelie
Van Hauwermeiren, Filip
Saavedra, Pedro H. V.
Šimon, Petr
Šubr, Vladimír
Kostka, Libor
Stivala, Craig E.
Pham, Victoria C.
Staben, Steven T.
Yamazoe, Sayumi
Konvalinka, Jan
Kayagaki, Nobuhiko
Lamkanfi, Mohamed
author_facet Walle, Lieselotte Vande
Stowe, Irma B.
Šácha, Pavel
Lee, Bettina L.
Demon, Dieter
Fossoul, Amelie
Van Hauwermeiren, Filip
Saavedra, Pedro H. V.
Šimon, Petr
Šubr, Vladimír
Kostka, Libor
Stivala, Craig E.
Pham, Victoria C.
Staben, Steven T.
Yamazoe, Sayumi
Konvalinka, Jan
Kayagaki, Nobuhiko
Lamkanfi, Mohamed
author_sort Walle, Lieselotte Vande
collection PubMed
description
format Online
Article
Text
id pubmed-6795414
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-67954142019-10-20 Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition Walle, Lieselotte Vande Stowe, Irma B. Šácha, Pavel Lee, Bettina L. Demon, Dieter Fossoul, Amelie Van Hauwermeiren, Filip Saavedra, Pedro H. V. Šimon, Petr Šubr, Vladimír Kostka, Libor Stivala, Craig E. Pham, Victoria C. Staben, Steven T. Yamazoe, Sayumi Konvalinka, Jan Kayagaki, Nobuhiko Lamkanfi, Mohamed PLoS Biol Correction Public Library of Science 2019-10-16 /pmc/articles/PMC6795414/ /pubmed/31618263 http://dx.doi.org/10.1371/journal.pbio.3000529 Text en © 2019 Walle et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Walle, Lieselotte Vande
Stowe, Irma B.
Šácha, Pavel
Lee, Bettina L.
Demon, Dieter
Fossoul, Amelie
Van Hauwermeiren, Filip
Saavedra, Pedro H. V.
Šimon, Petr
Šubr, Vladimír
Kostka, Libor
Stivala, Craig E.
Pham, Victoria C.
Staben, Steven T.
Yamazoe, Sayumi
Konvalinka, Jan
Kayagaki, Nobuhiko
Lamkanfi, Mohamed
Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition
title Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition
title_full Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition
title_fullStr Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition
title_full_unstemmed Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition
title_short Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition
title_sort correction: mcc950/crid3 potently targets the nacht domain of wild-type nlrp3 but not disease-associated mutants for inflammasome inhibition
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795414/
https://www.ncbi.nlm.nih.gov/pubmed/31618263
http://dx.doi.org/10.1371/journal.pbio.3000529
work_keys_str_mv AT wallelieselottevande correctionmcc950crid3potentlytargetsthenachtdomainofwildtypenlrp3butnotdiseaseassociatedmutantsforinflammasomeinhibition
AT stoweirmab correctionmcc950crid3potentlytargetsthenachtdomainofwildtypenlrp3butnotdiseaseassociatedmutantsforinflammasomeinhibition
AT sachapavel correctionmcc950crid3potentlytargetsthenachtdomainofwildtypenlrp3butnotdiseaseassociatedmutantsforinflammasomeinhibition
AT leebettinal correctionmcc950crid3potentlytargetsthenachtdomainofwildtypenlrp3butnotdiseaseassociatedmutantsforinflammasomeinhibition
AT demondieter correctionmcc950crid3potentlytargetsthenachtdomainofwildtypenlrp3butnotdiseaseassociatedmutantsforinflammasomeinhibition
AT fossoulamelie correctionmcc950crid3potentlytargetsthenachtdomainofwildtypenlrp3butnotdiseaseassociatedmutantsforinflammasomeinhibition
AT vanhauwermeirenfilip correctionmcc950crid3potentlytargetsthenachtdomainofwildtypenlrp3butnotdiseaseassociatedmutantsforinflammasomeinhibition
AT saavedrapedrohv correctionmcc950crid3potentlytargetsthenachtdomainofwildtypenlrp3butnotdiseaseassociatedmutantsforinflammasomeinhibition
AT simonpetr correctionmcc950crid3potentlytargetsthenachtdomainofwildtypenlrp3butnotdiseaseassociatedmutantsforinflammasomeinhibition
AT subrvladimir correctionmcc950crid3potentlytargetsthenachtdomainofwildtypenlrp3butnotdiseaseassociatedmutantsforinflammasomeinhibition
AT kostkalibor correctionmcc950crid3potentlytargetsthenachtdomainofwildtypenlrp3butnotdiseaseassociatedmutantsforinflammasomeinhibition
AT stivalacraige correctionmcc950crid3potentlytargetsthenachtdomainofwildtypenlrp3butnotdiseaseassociatedmutantsforinflammasomeinhibition
AT phamvictoriac correctionmcc950crid3potentlytargetsthenachtdomainofwildtypenlrp3butnotdiseaseassociatedmutantsforinflammasomeinhibition
AT stabenstevent correctionmcc950crid3potentlytargetsthenachtdomainofwildtypenlrp3butnotdiseaseassociatedmutantsforinflammasomeinhibition
AT yamazoesayumi correctionmcc950crid3potentlytargetsthenachtdomainofwildtypenlrp3butnotdiseaseassociatedmutantsforinflammasomeinhibition
AT konvalinkajan correctionmcc950crid3potentlytargetsthenachtdomainofwildtypenlrp3butnotdiseaseassociatedmutantsforinflammasomeinhibition
AT kayagakinobuhiko correctionmcc950crid3potentlytargetsthenachtdomainofwildtypenlrp3butnotdiseaseassociatedmutantsforinflammasomeinhibition
AT lamkanfimohamed correctionmcc950crid3potentlytargetsthenachtdomainofwildtypenlrp3butnotdiseaseassociatedmutantsforinflammasomeinhibition